SHENG-CHIEH CHOULin, Ching-YehChing-YehLinYen, Ching-TzuChing-TzuYenHsieh, Han-NiHan-NiHsiehHuang, Ying-ChihYing-ChihHuangKO-JEN LISHU-WHA LINMING-CHING SHEN2021-11-122021-11-122021-010929-6646https://scholars.lib.ntu.edu.tw/handle/123456789/586662Acquired factor XIII (FXIII) inhibitor is a rare but possibly underdiagnosed bleeding disorder. To date, less than one hundred cases have been reported, but the number has increased rapidly in recent years, especially in Japan. Because of the rarity of this disorder, no treatment guidelines are available. In some reports, physicians treated the bleeding with cryoprecipitate or factor XIII concentrate and eradicated the inhibitor with various immune suppressants.enAcquired inhibitor; Anti-factor XIII; Case series; Taiwanjournal article10.1016/j.jfma.2020.05.032325135062-s2.0-85085925304https://scholars.lib.ntu.edu.tw/handle/123456789/543925